A Single and Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of PU-AD in Healthy Subjects
Clinical trial NCT03935568 · TERMINATED
Trial details
- NCT number
- NCT03935568
- Sponsor
- Samus Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-24
- Primary completion
- 2019-12-23
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.